- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Events 227 results
Webinar
December 8, 2021
Talk im Turm – Impact of the new German sales law on the food and life sciences industries
Webinar
December 1, 2021
Ransomware for Healthcare Providers: What You Need To Know Right Now
Webinar
November 30, 2021
Pharmaceutical and Medical Device Enforcement Developments & Trends in 2021
Webinar
November 16, 2021
The Biden Administration’s New OSHA and CMS Rules: Implications for Healthcare Providers
Webinar
November 10, 2021
Let's Talk Tech – Preparing for Due Diligence in Technology-Related Deals
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
November 3, 2021
2nd Annual Cybersecurity & Privacy Seminar - Managing Cyber Risk: A New Frontier
Webinar
October 29, 2021
Nitrosamines and Beyond: The Future of Regulatory Actions and Litigation in a World of Contamination Claims
Webinar
October 28, 2021
Navigating the Federal Vaccine Mandate and the State Vaccine Mandate Bans: What Employers (Including Government Contractors) Can Expect
Webinar
October 28, 2021
Best Practices for Providers After They Receive a Payment Denial: Setting up Appeals and Disputes for Success
Webinar
September 30, 2021
Emerging Trends Regarding EPA’s Regulations Affecting Products: What Life Sciences Companies Should Know
Webinar
September 28, 2021
USMCA – Lessons Learned After the First Year: Origin, Labor, Autos, & Energy